Vicki L. Keedy
Hematology & Oncology · Vanderbilt Health Clinicians, LLC
Credentials: · · ·
History
Research
Soft Tissue Sarcoma, Version 2.2018, NCCN Clinical Practice Guidelines in Oncology
Journal of the National Comprehensive Cancer Network · 2018 · 495 citations
Structure-Guided Blockade of CSF1R Kinase in Tenosynovial Giant-Cell Tumor
New England Journal of Medicine · 2015 · 459 citations
Journal of Clinical Oncology · 2011 · First of 10 authors · 422 citations
9 papers
9 papers
9 papers
9 papers · 3 as a fellow
9 papers
8 papers
- SS
8 papers
- WT
8 papers
Grants
- 1997–2025
National Cancer Institute · P30
Project lead · $5.2M · Vanderbilt University Medical Center
Clinical trials
- 2013–2016
Quantitative Imaging Biomarkers of Treatment Response in Osteosarcoma and Ewing Sarcoma
Principal investigator · Terminated
Vanderbilt-Ingram Cancer Center
- 2009–2011
Principal investigator · Terminated · Phase 1
Vanderbilt-Ingram Cancer Center
- 2007–2014
Ph I/II Nab-Paclitaxel & Carboplatin w/Concurrent Radiation Therapy for Unresectable Stg III NSCLC
Principal investigator · Terminated · Phase 1, Phase 2
Vanderbilt-Ingram Cancer Center
- 2000–2008
Celecoxib in Treating Patients With Stage I, Stage II, or Stage IIIA Non-Small Cell Lung Cancer
Principal investigator · Completed
Vanderbilt-Ingram Cancer Center